Artificial Axon Labs Analysis
What is Artificial Axon Labs?
Artificial Axon Labs has developed a biomimetic platform for discovering medicines targeting neurodegenerative diseases. Their technology combines 3D printing of axon mimics with patient-derived human cells to directly measure myelination, focusing initially on Multiple Sclerosis. The platform has been validated through collaborations with industry and academic partners, including MIT.
Location
15 Forrest Rd, Topsfield, Massachusetts 01983, United States
Employees
1-10
Founded
2022
Funding Status
Seed
Product Features & Capabilities
- 3D-printed axon mimics
- Myelination quantification assays
- Drug screening platform for neurodegenerative diseases
Use Cases
Screen for remyelinating drugs in Multiple Sclerosis; Model myelin disorders in genetic variants of MS; Validate drug efficacy using human cell assays; Study human myelination processes; Investigate leukodystrophies using patient-derived cells
Other Considerations
Validated at MIT with industry collaborations; Won NIH SBIR Phase I award; Recognized in Sanofi IdeaTech 2023-24 award; Published research in collaboration with Sanofi
See something that needs updating? Suggest edits to this profile.